TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $398,000 | -28.4% | 17,995 | +0.2% | 0.00% | – |
| Q4 2020 | $556,000 | +63.5% | 17,960 | +7.4% | 0.00% | – |
| Q3 2020 | $340,000 | +76.2% | 16,730 | +33.0% | 0.00% | – |
| Q2 2020 | $193,000 | -34.6% | 12,575 | -67.0% | 0.00% | – |
| Q1 2020 | $295,000 | -47.3% | 38,135 | -2.8% | 0.00% | – |
| Q4 2019 | $560,000 | -8.2% | 39,215 | -3.4% | 0.00% | – |
| Q3 2019 | $610,000 | -64.7% | 40,610 | -66.3% | 0.00% | -100.0% |
| Q2 2019 | $1,726,000 | -28.1% | 120,600 | -12.5% | 0.00% | 0.0% |
| Q1 2019 | $2,401,000 | – | 137,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |